Pfizer acquisition of cancer drug company could advance oncology research

Published Online: Aug 23,2016 Laurie Toich, Assistant Editor Pfizer recently announced its plans to acquire Medivation, a biopharmaceutical company that develops molecules for oncology. Recent health insurer mergers could have deterred the $14 billion deal, but Pfizer and Medivation’s boards of directors approved the merger, and expect that shares will increase immediately, according to a press release from Pfizer. “The proposed …

Download Presentation: Are Virtual Clinical Trials The Panacea For Clinical Trials In Asia

At the last BioPharma Asia Convention 2013, Miguel Orri from Pfizer Ltd gave the following presentation entitled: Are Virtual Clinical Trials The Panacea For Clinical Trials In Asia Click here to download this presentation Some of the points covered by the presentation include: Current clinical research challenges and opportunities Revisiting the different roles in clinical trials Key elements in patient-centered …